Sgi-110 drug page Clinical trials

Trials with Sgi-110

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
2Countries
136Planned patients

Showing 1–2 of 2

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Finished Phase 1 18 patients NCT01966289

This study will be looking at whether CY/GVAX in combination with SGI-110 is effective (recruits CD45RO+ T cells to the tumor which may be a marker of anti-tumor activity) and safe in patients with metastatic colon or rectum cancers.

United States Apr 2014 – Jun 2020 Interventional
Combined with: Gvax
Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
Finished Phase 1 118 patients NCT01896856

This is a phase I/II study of the combination of Guadecitabine (SGI-110) and previously treated metastatic colorectal cancer patients. This study will be conducted in two components. First, patients will be enrolled in a phase I study of S…

United States, Netherlands Oct 2013 – Aug 2019 Interventional